Private Advisor Group’s Evogene EVGN Stock Holding History

Private Advisor Group’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,401	Closed	-$9.12K	–	2452
2024 Q2	$9.12K	Hold	1,401	–	–	﹤0.01%	2319
2024 Q1	$10.5K	Hold	1,401	–	–	﹤0.01%	2284
2023 Q4	$11.8K	Hold	1,401	–	–	﹤0.01%	2207
2023 Q3	$8.22K	Hold	1,401	–	–	﹤0.01%	2187
2023 Q2	$15K	Hold	1,401	–	–	﹤0.01%	1998
2023 Q1	$8.83K	Hold	1,401	–	–	﹤0.01%	1946
2022 Q4	$10	Hold	1,401	–	–	﹤0.01%	1655
2022 Q3	$12K	Hold	1,401	–	–	﹤0.01%	1889
2022 Q2	$11K	Hold	1,401	–	–	﹤0.01%	2090
2022 Q1	$18K	Hold	1,401	–	–	﹤0.01%	2070
2021 Q4	$23K	Sell	1,401 -50	-3%	-$1.14K	﹤0.01%	2106
2021 Q3	$38K	Buy	1,451 +100	+7%	+$2.92K	﹤0.01%	1988
2021 Q2	$46K	Buy	1,351 +150	+12%	+$5.88K	﹤0.01%	1938
2021 Q1	$61K	Buy	+1,201	New	+$74.3K	﹤0.01%	1839

Other funds holding EVGN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RIG

Renaissance Investment Group Lenox, Massachusetts $508M AUM 30.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Private Advisor Group's EVGN Position: Q3 2024 in Review

Private Advisor Group sold out of Evogene (EVGN) in Q3 2024, closing a stake of 1,401 shares — an estimated $9.12K sold.

Private Advisor Group first reported a position in EVGN in Q1 2021 and held it in 14 quarters. The position peaked at $61K in Q1 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

Private Advisor Group reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
Private Advisor Group sold 1,401 Evogene shares in Q3 2024, an estimated $9.12K.
Private Advisor Group first reported a position in Evogene in Q1 2021 and held it in 14 quarters.
Private Advisor Group's Evogene position peaked at $61K in Q1 2021.
14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Private Advisor Group's 13F filing for Q3 2024, filed 22 Oct 2024.